Shareholder Update: Mill City Gold Corp. Evaluating the Pharmaceutical Compounding Space

01.05.2015  |  Marketwired

CALGARY, May 1, 2015 - Mill City Gold Corp. ("Mill City" and/or the "Company") (TSX VENTURE:MC) (FRANKFURT:NJ6) is pleased to announce it is currently reviewing and evaluating a number of opportunities in the pharmaceutical compounding space.

Pharmaceutical compounding ("Compounding") is a branch of pharmacy that continues to play a crucial role of drug development. Compounding is the creation of a particular pharmaceutical product to fit the unique need of a patient. To do this, compounding pharmacists combine or process appropriate ingredients using various tools.


ON BEHALF OF THE BOARD OF DIRECTORS

James R. Brown
Chairman, President & CEO



The TSX Venture Exchange has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.



Contact

Mill City Gold Corp.
James R. Brown
403-640-0110
www.millcitygold.com